Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140714893> ?p ?o ?g. }
- W2140714893 endingPage "180" @default.
- W2140714893 startingPage "174" @default.
- W2140714893 abstract "The purpose of this study was to compare outcomes (and the effect of sacubitril/valsartan) according to etiology in the PARADIGM-HF (Prospective comparison of angiotensin-receptor-neprilysin inhibitor [ARNI] with angiotensin-converting-enzyme inhibitor [ACEI] to Determine Impact on Global Mortality and morbidity in Heart Failure) trial.Etiology of heart failure (HF) has changed over time in more developed countries and is also evolving in non-Western societies. Outcomes may vary according to etiology, as may the effects of therapy.We examined outcomes and the effect of sacubtril/valsartan according to investigator-reported etiology in PARADIGM-HF. The outcomes analyzed were the primary composite of cardiovascular death or HF hospitalization, and components, and death from any cause. Outcomes were adjusted for known prognostic variables including N terminal pro-B type natriuretic peptide.Among the 8,399 patients randomized, 5,036 patients (60.0%) had an ischemic etiology. Among the 3,363 patients (40.0%) with a nonischemic etiology, 1,595 (19.0% of all patients; 47% of nonischemic patients) had idiopathic dilated cardiomyopathy, 968 (11.5% of all patients; 28.8% of nonischemic patients) had a hypertensive cause, and 800 (9.5% of all patients, 23.8% of nonischemic patients) another cause (185 infective/viral, 158 alcoholic, 110 valvular, 66 diabetes, 30 drug-related, 14 peripartum–related, and 237 other). Whereas the unadjusted rates of all outcomes were highest in patients with an ischemic etiology, the adjusted hazard ratios (HRs) were not different from patients in the 2 major nonischemic etiology categories; for example, for the primary outcome, compared with ischemic (HR: 1.00), hypertensive 0.87 (95% confidence interval [CI]: 0.75 to 1.02), idiopathic 0.92 (95% CI: 0.82 to 1.04) and other 1.00 (95% CI: 0.85 to 1.17). The benefit of sacubitril/valsartan over enalapril was consistent across etiologic categories (interaction for primary outcome; p = 0.11).Just under one-half of patients in this global trial had nonischemic HF with reduced ejection fraction, with idiopathic and hypertensive the most commonly ascribed etiologies. Adjusted outcomes were similar across etiologic categories, as was the benefit of sacubitril/valsartan over enalapril. (Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure; NCT01035255)" @default.
- W2140714893 created "2016-06-24" @default.
- W2140714893 creator A5045656333 @default.
- W2140714893 date "2004-09-01" @default.
- W2140714893 modified "2023-09-27" @default.
- W2140714893 title "The management of intracranial hypertension in the perioperative period" @default.
- W2140714893 cites W1964622042 @default.
- W2140714893 cites W1964919195 @default.
- W2140714893 cites W1972377977 @default.
- W2140714893 cites W1977185671 @default.
- W2140714893 cites W1983630900 @default.
- W2140714893 cites W1990742838 @default.
- W2140714893 cites W1992417617 @default.
- W2140714893 cites W1995453564 @default.
- W2140714893 cites W1995712386 @default.
- W2140714893 cites W1996919524 @default.
- W2140714893 cites W2005258558 @default.
- W2140714893 cites W2007897189 @default.
- W2140714893 cites W2015609703 @default.
- W2140714893 cites W2016169463 @default.
- W2140714893 cites W2017701009 @default.
- W2140714893 cites W2022181678 @default.
- W2140714893 cites W2025620867 @default.
- W2140714893 cites W2028755131 @default.
- W2140714893 cites W2035722447 @default.
- W2140714893 cites W2041266085 @default.
- W2140714893 cites W2044990121 @default.
- W2140714893 cites W2046644524 @default.
- W2140714893 cites W2049538555 @default.
- W2140714893 cites W2056541767 @default.
- W2140714893 cites W2064429916 @default.
- W2140714893 cites W2067993363 @default.
- W2140714893 cites W2076093154 @default.
- W2140714893 cites W2077881791 @default.
- W2140714893 cites W2087157749 @default.
- W2140714893 cites W2092624051 @default.
- W2140714893 cites W2100501323 @default.
- W2140714893 cites W2112093154 @default.
- W2140714893 cites W2122348516 @default.
- W2140714893 cites W2126204041 @default.
- W2140714893 cites W2131595097 @default.
- W2140714893 cites W2135380777 @default.
- W2140714893 cites W2145838860 @default.
- W2140714893 cites W2155741230 @default.
- W2140714893 cites W2338871610 @default.
- W2140714893 cites W4238942122 @default.
- W2140714893 cites W4242521139 @default.
- W2140714893 cites W4245434331 @default.
- W2140714893 cites W4255142173 @default.
- W2140714893 doi "https://doi.org/10.1053/j.sane.2004.01.011" @default.
- W2140714893 hasPublicationYear "2004" @default.
- W2140714893 type Work @default.
- W2140714893 sameAs 2140714893 @default.
- W2140714893 citedByCount "1" @default.
- W2140714893 countsByYear W21407148932020 @default.
- W2140714893 crossrefType "journal-article" @default.
- W2140714893 hasAuthorship W2140714893A5045656333 @default.
- W2140714893 hasConcept C126322002 @default.
- W2140714893 hasConcept C134018914 @default.
- W2140714893 hasConcept C137627325 @default.
- W2140714893 hasConcept C164705383 @default.
- W2140714893 hasConcept C188816634 @default.
- W2140714893 hasConcept C207103383 @default.
- W2140714893 hasConcept C2777387769 @default.
- W2140714893 hasConcept C2778198053 @default.
- W2140714893 hasConcept C44249647 @default.
- W2140714893 hasConcept C555293320 @default.
- W2140714893 hasConcept C71924100 @default.
- W2140714893 hasConcept C78085059 @default.
- W2140714893 hasConcept C84393581 @default.
- W2140714893 hasConceptScore W2140714893C126322002 @default.
- W2140714893 hasConceptScore W2140714893C134018914 @default.
- W2140714893 hasConceptScore W2140714893C137627325 @default.
- W2140714893 hasConceptScore W2140714893C164705383 @default.
- W2140714893 hasConceptScore W2140714893C188816634 @default.
- W2140714893 hasConceptScore W2140714893C207103383 @default.
- W2140714893 hasConceptScore W2140714893C2777387769 @default.
- W2140714893 hasConceptScore W2140714893C2778198053 @default.
- W2140714893 hasConceptScore W2140714893C44249647 @default.
- W2140714893 hasConceptScore W2140714893C555293320 @default.
- W2140714893 hasConceptScore W2140714893C71924100 @default.
- W2140714893 hasConceptScore W2140714893C78085059 @default.
- W2140714893 hasConceptScore W2140714893C84393581 @default.
- W2140714893 hasIssue "3" @default.
- W2140714893 hasLocation W21407148931 @default.
- W2140714893 hasOpenAccess W2140714893 @default.
- W2140714893 hasPrimaryLocation W21407148931 @default.
- W2140714893 hasRelatedWork W2098118216 @default.
- W2140714893 hasRelatedWork W2357609130 @default.
- W2140714893 hasRelatedWork W2385466232 @default.
- W2140714893 hasRelatedWork W2622922034 @default.
- W2140714893 hasRelatedWork W2779222010 @default.
- W2140714893 hasRelatedWork W3033076790 @default.
- W2140714893 hasRelatedWork W3095613549 @default.
- W2140714893 hasRelatedWork W3155674270 @default.
- W2140714893 hasRelatedWork W3187572025 @default.
- W2140714893 hasRelatedWork W2035069710 @default.
- W2140714893 hasVolume "23" @default.